Tatsuaki Nakatou
Okayama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Cystatin C Confirms the Canagliflozin eGFR Slope Benefit in CANPIONE.
Journal: Kidney international reports
Published: October 31, 2025
A randomized, open-label, clinical trial examined the effects of canagliflozin on albuminuria and eGFR decline using an individual pre-intervention eGFR slope.
Journal: Kidney international
Published: March 03, 2024
Correction: Time course change of the insulin requirements during the perioperative period in hepatectomy and pancreatectomy by using an artificial pancreas STG-55.
Journal: Diabetology international
Published: July 03, 2023
Time course change of the insulin requirements during the perioperative period in hepatectomy and pancreatectomy by using an artificial pancreas STG-55.
Journal: Diabetology international
Published: October 12, 2022
Rationale, design and baseline characteristics of the effect of canagliflozin in patients with type 2 diabetes and microalbuminuria in the Japanese population: The CANPIONE study.
Journal: Diabetes, obesity & metabolism
Published: January 21, 2022
Marked Hypertriglyceridemia in a Patient with type 2 Diabetes Receiving SGLT2 Inhibitors.
Journal: Acta medica Okayama
Published: March 02, 2021
Cholinergic Crisis Owing to Distigmine Bromide Complicated by Hyperosmolar Hyperglycemic State.
Journal: Internal medicine (Tokyo, Japan)
Published: February 15, 2021
Hepatocellular carcinoma as a leading cause of cancer-related deaths in Japanese type 2 diabetes mellitus patients.
Journal: Journal of gastroenterology
Published: December 16, 2017
The Glucose-lowering Efficacy of Sitagliptin in Obese Japanese Patients with Type 2 Diabetes.
Journal: Internal medicine (Tokyo, Japan)
Published: March 22, 2017
Clinicopathological features of liver injury in patients with type 2 diabetes mellitus and comparative study of histologically proven nonalcoholic fatty liver diseases with or without type 2 diabetes mellitus.
Journal: Journal of gastroenterology
Published: June 04, 2012
Combination therapy with an angiotensin-converting-enzyme inhibitor and an angiotensin II receptor antagonist ameliorates microinflammation and oxidative stress in patients with diabetic nephropathy.
Journal: Journal of diabetes investigation
Published: April 03, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026